Health-related quality of life and cost-effectiveness of treatment in subarachnoid haemorrhage

European Journal of Neurology

Volumn 19, Issue 11, 2012, Pages 1455-1461

  Malmivaara, K ^a   Juvela, S ^b   Hernesniemi, J ^c   Lappalainen, J ^c   Siironen, J ^c  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cost effectiveness; Health related quality of life; Quality adjusted life year; Subarachnoid haemorrhage

Indexed keywords

ENOXAPARIN; PLACEBO;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROSURGERY; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; SURVIVOR; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WORK RESUMPTION;

ADULT; AGED; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; QUALITY-ADJUSTED LIFE YEARS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867733560     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03744.x     Document Type: Article

References (30)

1. Nieuwkamp DJ, Setz LE, Algra A, Linn FHH, de Rooij NK, Rinkel GJE. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009; 8: 635-642.
2. Ronne-Engström E, Enblad P, Lundström E. Outcome after spontaneous subarachnoid haemorrhage measured with the EQ-5D. Stroke 2011; 42: 3284-3286.
3. Leach MJ, Gall SL, Dewey HM, Macdonell RA, Thrift AG. Factors associated with quality of life in 7-year survivors of stroke. J Neurol Neurosurg Psychiatry 2011; 82: 1365-1371.
4. Wong GK, Poon WS, Boet R, et al. Health-related quality of life after aneurysmal subarachnoid haemorrhage: profile and clinical factors. Neurosurgery 2011; 68: 1556-1561.
5. Meyer B, Ringel F, Winter Y, et al. Health-related quality of life in patients with subarachnoid haemorrhage. Cerebrovascu Dis 2010; 30: 423-431.
6. Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid haemorrhage. Stroke 2010; 41: e519-e536.
7. Zubair Tahir M, Enam SA, Pervez Ali R, Bhatti A, ul Haq T. Cost-effectiveness of clipping vs coiling of intracranial aneurysms after subarachnoid haemorrhage in a developing country-a prospective study. Surg Neurol 2009; 72: 355-360.
8. Takao H, Nojo T, Ohtomo K. Screening for familial intracranial aneurysms: decision and cost-effectiveness analysis. Acad Radiol 2008; 15: 462-471.
9. Rivero-Arias O, Gray A, Wolstenholme J. Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc 2010; 27: 6.
10. Takao H, Nojo T, Ohtomo K. Treatment of ruptured intracranial aneurysms: a decision analysis. Br J Radiol 2008; 81: 299-303.
11. Bor AS, Koffijberg H, Wermer MJ, Rinkel GJ. Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis. Neurology 2010; 74: 1671-1679.
12. Hütter BO, Kreitschmann-Andermahr I, Gilsbach JM. Health-related quality of life after aneurysmal subarachnoid haemorrhage: impacts of bleeding severity, computerized tomography findings, surgery, vasospasm, and neurological grade. J Neurosurg 2001; 94: 241-251.
13. Siironen J, Juvela S, Varis J, et al. No effect of enoxaparin on outcome of aneurysmal subarachnoid haemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg 2003; 99: 953-959.
14. Juvela S, Siironen J. Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage. Eur J Neurol 2012; 19: 332-339.
15. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480-484.
16. Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. New York: Oxford University Press Inc., 2005.
17. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37: 53-72.
18. Ohinmaa A, Eija H, Sintonen H. Modelling EuroQol values of Finnish adult population. In: Badia X, Herdman M, Segura A, eds. EuroQol Plenary Meeting. Discussion Papers. Barcelona: Institut Universitari de Salut Publica de Catalunya, 1996: 67-76.
19. Ronkainen A, Niskanen M, Rinne J, Koivisto T, Hernesniemi J, Vapalahti M. Evidence for excess long-term mortality after treated subarachnoid haemorrhage.Stroke 2001; 32: 2850-2853.
20. Malmivaara K, Hernesniemi J, Salmenperä R, Ohman J, Roine RP, Siironen J. Survival and outcome of neurosurgical patients requiring ventilatory support after intensive care unit stay. Neurosurgery 2009; 65: 530-537.
21. Malmivaara K, Ohman J, Kivisaari R, Hernesniemi J, Siironen J. Cost-effectiveness of decompressive craniectomy in non-traumatic neurological emergencies. Eur J Neurol 2011; 18: 402-409.
22. Malmivaara K, Kivisaari R, Hernesniemi J, Siironen J. Cost-effectiveness of decompressive craniectomy in traumatic brain injuries. Eur J Neurol 2011; 18: 656-662.
23. Pakarinen S. Incidence, aetiology, and prognosis of primary subarachnoid haemorrhage. A study based on 589 cases diagnosed in a defined urban population during a defined period. Acta Neurol Scand 1967; 43: 1-128.
24. Juvela S. Platelet aggregation and thromboxane release in primary subarachnoid haemorrhage [dissertation]. Yliopistopaino, Helsinki: University of Helsinki, 1991.
25. Pickard JD, Bailey S, Sanderson H, Rees M, Garfield JS. Steps towards cost-benefit analysis of regional neurosurgical care. BMJ 1990; 301: 629-635.
26. Greebe P, Rinkel GJ, Hop JW, Visser-Meily JM, Algra A. Functional outcome and quality of life 5 and 12.5 years after aneurysmal subarachnoid haemorrhage. J Neurol 2010; 257: 2059-2064.
27. Rinkel GJ, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol 2011; 10: 349-356.
28. Passier PE, Visser-Meily JM, Rinkel GJ, Lindeman E, Post MW. Life satisfaction and return to work after aneurysmal subarachnoid haemorrhage. J Stroke Cerebrovascu Dis 2011; 20: 324-329.
29. Kassell NF, Adams HP Jr, Torner JC, Sahs AL. Influence of timing of admission after aneurysmal subarachnoid haemorrhage on overall outcome. Report of the cooperative aneurysm study. Stroke 1981; 12: 620-623.
30. Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50, 000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 2008; 8: 165-178.